National Trends and Factors Associated with Ischemic Heart Disease Among Individuals with Hypertension in Thailand from 2011 to 2018

2011年至2018年泰国高血压患者缺血性心脏病发病率的全国趋势及相关因素

阅读:6

Abstract

BACKGROUND: Epidemiological data on ischemic heart disease (IHD) in individuals with hypertension in Thailand are limited. We examined national trends and factors associated with IHD among individuals with hypertension in Thailand from 2011 to 2018, following a decade of universal health coverage (UHC) implementation. METHODS: We conducted a repeated cross-sectional study using data from the Thailand DM/HT study. This study included 226,420 Thai people aged ≥20 years with hypertension who received outpatient care nationwide. The annual prevalence and incidence of IHD were estimated. Modified Poisson regression analysis identified associated factors. RESULTS: Across the 2011-2018 cycles, the age- and sex-adjusted IHD prevalence decreased from 56.6 to 34.5 per 1,000 people (p-trend < 0.001), and the incidence decreased from 9.8 to 4.0 per 1,000 people (p-trend < 0.001). This pattern was observed in both sexes. Men had a higher IHD incidence than women (adjusted risk ratio [aRR]: 1.32; 95% confidence interval [CI]: 1.12-1.56). IHD risk increased with age. Sex modified the effect of age on IHD incidence. Priests were at a higher risk of IHD than agriculturists (aRR: 2.45; 95% CI: 1.46-4.10). IHD incidence was higher in the Central (aRR: 1.49; 95% CI: 1.13-1.96) and Southern (aRR: 1.48; 95% CI: 1.04-2.10) regions than in the Northeast. IHD risk varied based on healthcare coverage scheme and treatment location. Individuals with comorbidities such as diabetes (aRR: 1.20; 95% CI: 1.01-1.43) and chronic kidney disease (aRR: 1.52; 95% CI: 1.30-1.79) had an increased IHD risk. CONCLUSION: After a decade of UHC implementation, Thailand witnessed a reduction in IHD prevalence and incidence among individuals with hypertension from 2011 to 2018. Nevertheless, further opportunities exist to mitigate the IHD risk within this population. Policymakers can use this evidence to prioritize efforts toward reducing the risk of IHD in individuals with hypertension.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。